Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D001593:Benzyl Compounds; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D002986:Clinical Trials as Topic; D003863:Depression / Q000097:blood / Q000188:drug therapy / Q000201:enzymology*; D004200:Diseases in Twins; D005260:Female; D005500:Follow-Up Studies; D006579:Heterozygote; D006624:Hippocampus / Q000201:enzymology; D006720:Homozygote; D006801:Humans; D007527:Isoenzymes / Q000097:blood / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000097:blood / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D012559:Schizophrenia / Q000097:blood / Q000201:enzymology*; D013997:Time Factors; D014363:Tryptamines; D014427:Twins
D001593:Benzyl Compounds; D007527:Isoenzymes; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D008995:Monoamine Oxidase